Preparation method of core-shell type hydrogel microspheres for wrapping xanthogenic bacteria and production application of core-shell type hydrogel microspheres for cultivating calculus bovis in cattle body

By minimally invasively implanting core-shell structured hydrogel microspheres encapsulating flavonoids into the bovine gallbladder, the problems of complex operation and low conversion efficiency in bovine gallbladder culture have been solved, achieving efficient and stable bovine gallbladder production.

CN121950559APending Publication Date: 2026-05-01SICHUAN MICROFLUIDIC TECH CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202511837090.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-12-08
Publication Date
2026-05-01

AI Technical Summary

Technical Problem

The existing technology for cultivating bezoar is complex and cumbersome, causing strong stress on cattle, high risk of infection, low bilirubin conversion efficiency, and difficulty in enriching the small bilirubin particles generated in the early stages, resulting in low bezoar yield, long cycle and unstable quality.

Method used

A core-shell structured hydrogel microsphere encapsulating flavogenic bacteria was implanted into the bovine gallbladder via a minimally invasive procedure. The core-shell hydrogel microspheres, containing flavogenic bacteria and specific β-glucuronidase antibodies, were prepared using microfluidic technology to form a core-shell structure that supports microbial colonization and bilirubin conversion.

Benefits of technology

This technology enables minimally invasive surgery, reducing the risk of injury and infection in cattle, improving bilirubin conversion efficiency, shortening the bilirubin formation cycle, increasing the yield and quality of bezoar, and meeting pharmacopoeia standards.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 9RWINGRW2CLWSSMTCJUSHVBCDW7WT5CMZ3G7LXBW
    Figure 9RWINGRW2CLWSSMTCJUSHVBCDW7WT5CMZ3G7LXBW
  • Figure ANXYTQM1AJ8QPHJMPM6GYYOCJ3O2MNJI1HOK5FO9
    Figure ANXYTQM1AJ8QPHJMPM6GYYOCJ3O2MNJI1HOK5FO9
  • Figure DALBPZLLXZFSND1DJE40LWGPFMMVDN6PIVCXZMIX
    Figure DALBPZLLXZFSND1DJE40LWGPFMMVDN6PIVCXZMIX
Patent Text Reader

Abstract

The invention discloses a preparation method of a core-shell type hydrogel microsphere wrapping xanthogenic bacteria and production application of the core-shell type hydrogel microsphere in cultivation of calculus bovis in a cattle body. The preparation method specifically comprises the following steps: S1, preparing an external phase solution; S2, preparing a shell solution; S3, preparing a core solution; according to the application, the specially-made core-shell hydrogel microspheres are implanted through minimally invasive surgery, the microspheres can realize long-term efficient colonization of yellow bacteria so as to improve the bilirubin conversion efficiency, and also can specifically adsorb key enzymes and bilirubin particles, so that the yellowing period is remarkably shortened, and meanwhile, the high success rate and the high quality of calculus bovis are guaranteed.
Need to check novelty before this filing date? Find Prior Art

Description

Preparation method of core-shell hydrogel microspheres encapsulating flavonoids and their application in the production of bovine bezoar culture. Technical Field

[0001] This invention relates to the field of bezoar production technology, specifically a method for preparing core-shell hydrogel microspheres encapsulating flavonoids and their application in the production of bezoar cultured in cattle. Background Technology

[0002] Bezoar, a traditional Chinese medicine, is a key ingredient in many prepared Chinese medicines and has shown significant efficacy against numerous diseases. my country's annual demand for bezoar is 5-6 tons, while the production of natural bezoar is extremely scarce, with national annual production not exceeding 1000 kg, and demand continues to rise. Cultured bezoar, with a formation process most similar to natural bezoar, has comparable medicinal effects. The National Medical Products Administration has issued regulations allowing cultured bezoar to be used as a substitute for natural bezoar in prescriptions, in equal amounts.

[0003] In vivo cultivation of bezoar involves surgically implanting a biliary fossa into the gallbladder of a live bovine animal and injecting a specific strain of bacteria that secretes β-glucuronidase. This bacteria converts conjugated bilirubin in the bile into a gallstone-like substance, which is then cultivated over a long period to form bezoar. Since the 1970s, China has been working on developing bezoar cultivation technology. However, to date, this technology faces numerous challenges and has not yet achieved large-scale production and application. The main problems are: (1) The surgery requires an 8-15 cm incision on the right side of the cow's body, and the gallbladder is removed from the body. The gallbladder is then cut open and the bilirubin culture is implanted. The process is complicated and the operation is cumbersome, resulting in strong stress response, slow recovery and high risk of infection in the cattle; (2) The culture has no attachment point and cannot colonize the body for a long time. After being injected into the gallbladder, it is expelled from the gallbladder with the secretion of bile and fails to achieve the corresponding conversion effect; (3) The bilirubin microparticles formed in the early stage are very small, and the pore size of the bilirubin bed is limited, so the bilirubin cannot be enriched. Only larger bilirubin particles can be collected. The small bilirubin particles generated in the early stage are discharged into the digestive system, resulting in a long bilirubin formation cycle, low probability and low yield. In terms of quality, the bilirubin content is difficult to meet the requirement of >25% in the 2025 edition of the Pharmacopoeia of the People's Republic of China; (4) β-glucuronidase is easily excreted with bile, resulting in low conversion efficiency of bilirubin calcium.

[0004] Immobilized microorganisms (MIT) are a technique that uses physicochemical methods to immobilize microorganisms on specific carriers. Currently, commonly used bacterial immobilization methods include adsorption, covalent bonding, and encapsulation. Encapsulation involves embedding microorganisms in porous materials such as fibers and natural gel polymers; it is an irreversible immobilization method. This method aims to incorporate microbial cells into a rigid and resistance-resistant network structure that allows substrates and nutrients to enter and contact the microorganisms while providing space for growth and reproduction. The selection of the carrier or support material is a crucial step in immobilized microorganisms, affecting not only the activity of the microorganisms on the carrier but also the degradation efficiency during treatment. Composite materials, which are prepared by synthesizing two or more materials, combine inorganic materials and hydrogel materials, providing a highly biocompatible attachment site for flavonoids and improving the mechanical properties of the carrier material.

[0005] Currently, among existing technologies, patent CN117562927A discloses the direct in vitro hydrolysis of bilirubin using β-glucuronidase but does not disclose its targeted action in vivo; CN119351284A only discloses the in vitro application of compound flavinogenic bacteria, failing to address the harsh environmental problem of strains' colonization in vivo; while CN119367398A involves in vivo strain encapsulation, its "compound mucin paste" encapsulation method is not suitable for increasing bezoar yield. In summary, there is an urgent need for a method to prepare core-shell structured hydrogel microspheres encapsulating flavinogenic bacteria and its application in the production of bezoar cultured in cattle, to improve bilirubin conversion efficiency, specifically adsorb key enzymes and bilirubin particles, shorten the bilirubin formation cycle, and ensure a high success rate and superior quality of bezoar. Summary of the Invention

[0006] The purpose of this invention is to overcome the shortcomings of the prior art and provide a method for preparing core-shell structured hydrogel microspheres encapsulating flavonoids and their application in the production of bovine bezoar culture.

[0007] The objective of this invention is achieved through the following technical solution: Firstly, a method for preparing core-shell structured hydrogel microspheres encapsulating flavogenic bacteria, comprising the following steps: S1: Preparing the outer phase solution: Adding surfactant ABIL EM90 to liquid paraffin, stirring to dissolve it, then adding glacial acetic acid, and shaking to mix, to obtain the outer phase solution; S2: Preparing the shell solution: Dissolving an amino-containing biocompatible material and a carboxyl-containing biocompatible material in MES buffer, and mixing with Ca-EDTA solution to obtain a shell base solution; adding EDC and NHS to the shell base solution, then adding a β-glucuronidase polyclonal antibody solution, and shaking the reaction at room temperature to form amide bonds between the amino groups and the carboxyl groups of the β-glucuronidase polyclonal antibody activated by EDC / NHS; after the reaction, rinsing to obtain the shell solution; S3: Preparing the core solution: [The text abruptly ends here, likely due to an incomplete translation or a missing section.] The culture medium and sodium hyaluronate solution are mixed and stirred at a volume ratio of 1:1 to obtain the core solution; S4: Microfluidic preparation of core-shell droplets and microspheres: Using a microfluidic chip, the three-phase solution is injected into the microfluidic chip, so that the core solution is wrapped by the shell solution to form a core-shell bilayer droplet. Under the shearing action of the outer phase solution, it is dispersed into micron-sized droplets. The reaction continues, and the core-shell structure is completely solidified to obtain a suspension of the core-shell hydrogel microspheres encapsulating flavoxant bacteria; S5: Microsphere collection: The suspension of the core-shell hydrogel microspheres encapsulating flavoxant bacteria is centrifuged, and the lower layer of hydrogel microspheres is collected. After washing, the core-shell hydrogel microspheres encapsulating flavoxant bacteria are obtained.

[0008] Specifically, the core-shell hydrogel microspheres encapsulating flavophytes have a particle size of 50-500 μm and an encapsulation rate of ≥90%; specifically, in S1, the volume ratio of liquid paraffin, ABIL EM90, and glacial acetic acid is 100:3:1, the stirring speed is 150-500 rpm, and the stirring time is 6-10 h; preferably, the stirring speed is 300 rpm, and the stirring time is 8 h; specifically, in S2, the pH of the MES buffer is 5.5 to maintain EDC activity; the concentration of the Ca-EDTA solution is 240 mM; the molar ratio of carboxyl group content in the EDC, NHS, and β-glucuronidase polyclonal antibody is 0.6-1.2:0.5-1.0:0.8-1.4; and the shaking reaction time is 4-6 hours. h; The rinsing includes repeated rinsing with PBS buffer to remove unreacted EDC, NHS, and β-glucuronidase polyclonal antibody solution; specifically, the carboxyl-containing biocompatible materials include hyaluronic acid, alginate, carboxymethyl cellulose, and PLGA; the amino-containing biocompatible materials include chitosan, gelatin, and aminolated PEG; wherein, the amino group of chitosan forms an amide bond with the carboxyl group of the β-glucuronidase polyclonal antibody activated by EDC / NHS, and Ca-EDTA releases Ca in the presence of glacial acetic acid during subsequent microfluidic preparation. 2+ Ionic crosslinking of sodium alginate.

[0009] Specifically, in S3, the concentration of the sodium hyaluronate solution is 1% w / v; the flavonoid is *Enterococcus faecium* WLK001JZ=7#, deposited at the Guangdong Provincial Center for Microbial Culture Collection, accession number GDMCC No. 65630, on December 13, 2024; the viable count of the flavonoid is 10. 6 ~10 9 CFU / mL; the stirring conditions are a sterile environment, and the stirring time is 30 min; preferably, in S4, the use of chip control includes: using a coaxial glass tube chip or PDMS chip as a microfluidic device, and injecting a syringe pump at flow rates of 2-20 µL / min for the core solution; 5-50 µL / min for the shell solution; and 40-200 µL / min for the external phase solution; the continuous reaction time is 30-480 min; glacial acetic acid in the external phase provides H₂. + It binds to EDTA in the shell solution, releasing Ca. 2+ Ca 2+ An ionic cross-linking reaction occurs with sodium alginate to form a gel network; specifically, in S5, the centrifugation speed is 1000 rpm and the centrifugation time is 5 min; the washing includes washing three times with sterile physiological saline.

[0010] In a second aspect, there is an injectable dispersion of flavogenic bacteria gel microspheres, wherein the dispersion is formed by mixing the core-shell hydrogel microspheres encapsulating flavogenic bacteria as described in claims 1 to 8 with sterile physiological saline, wherein the microspheres are uniformly dispersed in physiological saline and are suitable for implantation into the gallbladder or related target sites in animals via puncture injection.

[0011] Thirdly, the application of core-shell structured hydrogel microspheres encapsulating flavogenic bacteria includes implanting the microsphere dispersion into the gallbladder or hepatobiliary-related sites of cattle or other ruminants via puncture injection, thereby promoting the efficient and stable generation of bezoar in vivo under the growth and metabolism of flavogenic bacteria.

[0012] The beneficial effects of this invention are: (1) This application adopts minimally invasive operation, reducing injury to cattle, using a 10 G-30 G puncture needle, with an incision of <1 cm, eliminating the need to open the abdominal cavity and remove the gallbladder, shortening the operation time to 20-30 min, which is 70% less than traditional techniques. The above; the postoperative wound infection rate was reduced to below 3%, the recovery period was shortened to 7-10 days, the stress response of cattle was significantly reduced, the postoperative culling rate was reduced to below 1%, and the normal fattening of cattle was not affected; (2) the core-shell hydrogel microspheres containing flavophytes prepared in this application can colonize efficiently and improve the conversion efficiency. In the core-shell hydrogel microspheres containing flavophytes, the microsphere channel structure provides nutrition and protection for flavophytes. The sodium alginate / chitosan shell layer can be slowly degraded in the gallbladder, with a degradation period of 3-6 months, so as to achieve continuous release and colonization of flavophytes; according to the test, the colonization time of flavophytes in the gallbladder was extended to more than 10 months, and the conversion efficiency of bilirubin was increased to more than 75%, providing a sufficient material basis for the formation of bezoar; (3) the hydrogel microspheres prepared in this application specifically adsorb and enhance enrichment, which can effectively improve the quality of bezoar production. The shell and core layers of the hydrogel microspheres have viscous adsorption characteristics and can effectively adsorb diameter >1 μm The bilirubin particles have an adsorption rate of over 85%; the shell contains a polyclonal antibody against β-glucuronidase that can specifically adsorb β-glucuronidase and promote its conversion of bilirubin calcium; at the same time, the precipitation-promoting effect of the gel microspheres can accelerate the aggregation of bilirubin particles, shortening the yellowing cycle to 6-12 months, which is 30%-50% less than the traditional technology, and increasing the yellowing probability to over 85%. The bilirubin content in the collected bezoar is stable at ≥25%, which meets the pharmacopoeia standard; (4) The puncture and yellowing device of this application has a simple structure and low cost. The hydrogel microspheres can be prepared in batches through microfluidic technology, and 10 microspheres can be prepared per hour. 5 -10 6 The procedure can be performed without the need for a professional surgeon; a trained veterinarian can complete it, laying the foundation for the large-scale application of in vivo bezoar cultivation technology. Attached Figure Description

[0013] Figure 1 is a schematic diagram of the preparation of core-shell structured hydrogel microspheres encapsulating flavophytes according to this application; Figure 2 is a physical image of the core-shell structured hydrogel microspheres encapsulating flavophytes shown in Example 1; Figure 3 is an optical microscope image (magnification 100x) of the core-shell structured hydrogel microspheres encapsulating flavophytes in Example 1; Figure 4 is a scanning electron microscope image (Figure a is an image of the core-shell structured hydrogel microspheres encapsulating flavophytes at 100x magnification; Figure b is an image of the core-shell structured hydrogel microspheres encapsulating flavophytes) in Example 1. Figure 5 shows the bezoar images obtained after the experiment in Comparative Example 2 (Figure a shows the bezoar yield of WLKSYN004, Figure b shows the bezoar yield of WLKSYN005, and Figure c shows the bezoar yield of WLKSYN006); Figure 6 shows the bezoar images obtained after the experiment in Example 1 (Figure a shows the bezoar yield of WLKSYN0010, Figure b shows the bezoar yield of WLKSYN0011, and Figure c shows the bezoar yield of WLKSYN0012). Detailed Implementation

[0014] The technical solution of the present invention will be further described in detail below with reference to the accompanying drawings, but the scope of protection of the present invention is not limited to the following description.

[0015] Comparative Example 1: Microbial inoculation via puncture surgery for bezoar production (1) Activation of bacterial strains: Enterococcus faecalis was used as a flammating bacterium. The preserved Enterococcus faecalis strain was inoculated into sterile LB liquid medium and cultured in a constant temperature shaker at 37°C and 200 rpm for about 12-16 h to allow it to recover and reach a sufficient growth density for subsequent experiments.

[0016] (2) Cattle screening before puncture: Select 5 Simmental cattle or local yellow cattle (sex not limited) aged 6-8 months, weighing 300-500 kg, and in good health; exclude cattle with hepatobiliary diseases, infectious diseases, and immunodeficiency through clinical examination (body temperature, heart rate, respiration) and laboratory tests (complete blood count, liver function, bile routine); number them WLKSYN001, WLKSYN002, and WLKSYN003 respectively; Cattle restraint: Use the lateral recumbent restraint method to fix the cattle on a special restraint frame with the right side of the body facing upward; shave the right rib area (10th-12th intercostal area) of the cattle, with a shaving area of ​​20 cm × 20 cm, and disinfect the area 3 times with iodine solution (disinfect in a spiral motion from the inside out, with the disinfection area extending 5 cm beyond the shaving area). cm); Anesthesia: Local infiltration anesthesia was used. 2% lidocaine solution was injected in a fan shape along the puncture point (the center of the gallbladder projection located by ultrasound). The anesthesia area was 5 cm in diameter and the depth reached the muscle layer. After anesthesia, wait 5 minutes to confirm the anesthetic effect.

[0017] (3) Gallbladder localization during puncture: Apply coupling gel to the portable veterinary ultrasound probe and place it in the disinfected area of ​​the right rib of the cow. Adjust the probe angle (45° to the horizontal plane) and observe the ultrasound image in real time to determine the location, size, and thickness of the gallbladder wall. Mark the puncture point (usually located in the 11th intercostal space). Puncture and drug injection: Insert the 18G puncture needle into the skin and then slowly push it in. Under real-time ultrasound monitoring, the puncture needle passes through the muscle layer and peritoneum until the needle tip enters the gallbladder cavity (the ultrasound image shows that the needle tip is located in the anechoic bile of the gallbladder and there is no blood reflux). Remove the needle core of the puncture needle and connect the syringe containing the injection solution (the injection solution is made by mixing hydrogel microspheres containing flavophytes and physiological saline at a volume ratio of 1:1. The injection volume per cow is 5-50 mL, containing 10 g of flavophytes). 9 -10 10 (CFU); Slowly push the syringe plunger, controlling the push pressure to <5 N through the pressure feedback device to avoid gallbladder wall rupture; After injection, pause for 30 seconds to ensure the medication completely enters the gallbladder; Slowly withdraw the puncture needle, press the puncture site with sterile gauze for 5 minutes to stop bleeding, then apply erythromycin ointment, cover with sterile dressing, and fix with an elastic bandage; Post-puncture monitoring: Continuously observe the cattle's mental state, respiration, and heart rate within 30 minutes after the procedure. After confirming no abnormal reactions, transfer the cattle to a separate pen for rearing.

[0018] (4) Post-puncture care: Disinfect and bandage the puncture wound, observe the wound healing regularly to prevent infection; provide cattle with nutritious and easily digestible feed to promote their recovery and healthy growth.

[0019] (5) Feeding and bilirubin extraction: The experimental cattle were properly cared for. After 12 months of care, they were slaughtered and bilirubin was extracted. After drying the bilirubin at 37°C, the weight of the bilirubin was measured. The bilirubin content of the obtained bilirubin was tested using the detection method under the entry for bilirubin in Part I of the Chinese Pharmacopoeia 2025. The remaining bile was purified and preserved by bacteria, and the bile was diluted and plated for counting. The bilirubin yield, bilirubin content, bacterial purification results and bacterial count results are shown in Table 1.

[0020] Comparative Example 2: Microspheres containing flavonoid strains used in post-injection bezoar production (1) Preparation of microsphere solution: Take 100 mL of liquid paraffin, add 3 mL of ABIL EM90, and stir at 300 rpm for 8 h at 25℃ to fully dissolve the surfactant; then add 1 mL of glacial acetic acid, shake for 10 min until mixed evenly, and set aside; Preparation of core solution: Stir 1% w / v sodium hyaluronate solution evenly under sterile conditions, and then mix the mixed solution with flavogenic bacteria liquid culture medium (containing activated flavogenic bacteria, bacterial concentration of 10). 6 -10 9Mix (CFU / mL) at a volume ratio of 1:1 and stir under aseptic conditions for 30 min.

[0021] (2) Preparation of microspheres: Connect each phase solution to the inlet of the microfluidic chip, turn on the injection pump, and adjust the flow rate of the inner phase to 5-10 μL / min; the flow rate of the intermediate phase to 30-40 μL / min; and the flow rate of the outer phase to 180-200 μL / min. After shearing out the microspheres, solidify them in the receiving phase for 30 min. Then, centrifuge the mixture in the collecting device at 1000 rpm for 5 min and collect the lower layer of hydrogel microspheres. Wash three times with sterile physiological saline to remove residual oil phase and uncrosslinked substances, and obtain core-shell hydrogel microspheres encapsulating flavogenic bacteria for later use.

[0022] (3) Preparation of injection solution: Preparation of gel microsphere solution of flavogenic bacteria: Mix gel microspheres of flavogenic bacteria with physiological saline to form a dispersion solution.

[0023] (4) Cattle screening before puncture: Select 5 Simmental cattle or local yellow cattle (sex not limited) aged 6-8 months, weighing 300-500 kg, and in good health; exclude cattle with hepatobiliary diseases, infectious diseases, and immunodeficiency through clinical examination (body temperature, heart rate, respiration) and laboratory tests (complete blood count, liver function, bile count); number them WLKSYN004, WLKSYN005, and WLKSYN006 respectively; Cattle restraint: Use the lateral recumbent restraint method to fix the cattle on a special restraint frame with the right side of the body facing upward; shave the right rib area (10th-12th intercostal area) of the cattle, with a shaving area of ​​20 cm × 20 cm, and disinfect the area 3 times with iodine solution (disinfect in a spiral motion from the inside out, with the disinfection area extending 5 cm beyond the shaving area). cm); Anesthesia: Local infiltration anesthesia was used. 2% lidocaine solution was injected in a fan shape along the puncture point (the center of the gallbladder projection located by ultrasound). The anesthesia area was 5 cm in diameter and the depth reached the muscle layer. After anesthesia, wait 5 minutes to confirm the anesthetic effect.

[0024] (5) Gallbladder localization during puncture surgery: Apply coupling gel to the portable veterinary ultrasound probe and place it in the disinfected area of ​​the right rib of the cow. Adjust the probe angle (45° to the horizontal plane) and observe the ultrasound image in real time to determine the location, size, and thickness of the gallbladder wall. Mark the puncture point (usually located in the 11th intercostal space). Puncture and injection: Insert the 18G puncture needle into the skin and then slowly push it in. Under real-time ultrasound monitoring, the puncture needle passes through the muscle layer and peritoneum until the needle tip enters the gallbladder cavity (the ultrasound image shows that the needle tip is located in the anechoic bile of the gallbladder and there is no blood reflux). Remove the needle core of the puncture needle and connect the syringe containing the injection solution (the injection solution is made by mixing hydrogel microspheres containing flavophytes and physiological saline at a volume ratio of 1:1. The injection volume per cow is 5-50 mL, containing 10 flavophytes). 9 -10 10 (CFU); Slowly push the syringe plunger, controlling the push pressure to <5 N through the pressure feedback device to avoid gallbladder wall rupture; After injection, pause for 30 seconds to ensure the medication completely enters the gallbladder; Slowly withdraw the puncture needle, press the puncture site with sterile gauze for 5 minutes to stop bleeding, then apply erythromycin ointment, cover with sterile dressing, and fix with an elastic bandage; Postoperative monitoring: Continuously observe the cattle's mental state, respiration, and heart rate within 30 minutes after surgery. After confirming no abnormal reactions, transfer the cattle to a separate pen for rearing.

[0025] (7) Post-puncture care: Disinfect and bandage the puncture wound, observe the wound healing regularly to prevent infection; provide the cattle with nutritious and easily digestible feed to promote the cattle's recovery and healthy growth. (8) Feeding and yolk extraction: Provide normal care to the cattle after the operation. When the experimental cattle have been cared for for 12 months, slaughter them to extract yolk. The amount of yolk extracted and the results of bacterial culture are shown in Table 1.

[0026] Comparative Example 3: Hydrogel core-shell microspheres used in post-injection bezoar production (1) Preparation of microsphere solution: Take 100 mL of liquid paraffin, add 3 mL of ABIL EM90, stir at 300 rpm for 8 h at 25℃ to fully dissolve the surfactant; then add 1 mL of glacial acetic acid, shake for 10 min until mixed evenly, and set aside; Preparation of shell solution: Dissolve chitosan and sodium alginate in MES buffer (pH 5.5, to maintain EDC activity), and mix with 240 mM Ca-EDTA solution; Preparation of core solution: Stir 1% w / v sodium hyaluronate solution evenly under sterile conditions, and stir for 30 min under sterile conditions, and set aside.

[0027] (2) Preparation of microspheres: Connect each phase solution to the inlet of the microfluidic chip, turn on the injection pump, and adjust the flow rate of the inner phase to 5-10 μL / min; the flow rate of the intermediate phase to 30-40 μL / min; and the flow rate of the outer phase to 180-200 μL / min. After shearing out the microspheres, solidify them in the receiving phase for 30 min. Then, centrifuge the mixture in the collecting device at 1000 rpm for 5 min and collect the lower layer of hydrogel microspheres. Wash three times with sterile physiological saline to remove residual oil phase and uncrosslinked substances, and obtain core-shell hydrogel microspheres encapsulating flavogenic bacteria for later use.

[0028] (3) Preparation of injection solution: Preparation of gel microsphere solution of flavogenic bacteria: Mix gel microspheres of flavogenic bacteria with physiological saline to form a dispersion solution.

[0029] (4) Cattle screening before puncture: Select 5 Simmental cattle or local yellow cattle (sex not limited) aged 6-8 months, weighing 300-500 kg, and in good health; exclude cattle with hepatobiliary diseases, infectious diseases and immunodeficiency through clinical examination (body temperature, heart rate, respiration) and laboratory tests (complete blood count, liver function, bile count); number them WLKSYN007, WLKSYN008 and WLKSYN009 respectively; Cattle restraint: use the lateral recumbent restraint method to fix the cattle on a special restraint frame with the right side of the body facing up; shave the hair on the right side of the cattle (between the 10th and 12th ribs) in an area of ​​20 cm × 20 cm, and disinfect the area 3 times with iodine solution (disinfect in a spiral motion from the inside out, and the disinfection area extends 5 cm beyond the shaved area). cm); Anesthesia: Local infiltration anesthesia was used. 2% lidocaine solution was injected in a fan shape along the puncture point (the center of the gallbladder projection located by ultrasound). The anesthesia area was 5 cm in diameter and the depth reached the muscle layer. After anesthesia, wait 5 minutes to confirm the anesthetic effect.

[0030] (5) Puncture implantation: 20 mL of antibody-binding microspheres and 10 mL of Enterococcus faecalis were implanted into the Simmental cattle through puncture surgery. Ultrasound was used to ensure that the microspheres were implanted into the gallbladder.

[0031] (6) Feeding and extracting bezoar: The experimental cattle were fed normally. After 12 months of feeding, they were slaughtered and bezoar was extracted, yielding 32g of bezoar.

[0032] (7) Bezoar detection: The experimental cattle were kept under normal care. After 12 months of care, they were slaughtered and bezoar was extracted. The amount of bezoar extracted and the results of bacterial strains are shown in Table 1.

[0033] Example 1: Core-shell microspheres with specific β-glucuronidase binding for post-injection bezoar production(1) Preparation of microsphere solution: Take 100 mL of liquid paraffin, add 3 mL of ABIL EM90, stir at 300 rpm for 8 h at 25℃ to fully dissolve the surfactant; then add 1 mL of glacial acetic acid, shake for 10 min until mixed evenly, and set aside; Preparation of shell solution: Dissolve chitosan and sodium alginate in MES buffer (pH 5.5, to maintain EDC activity), mix with 240 mM Ca-EDTA solution; then add EDC and NHS, and then add β-glucuronidase polyclonal antibody solution; shake at room temperature for 4-6 hours, the -NH2 of chitosan and the activated carboxyl group (NHS ester) of β-glucuronidase polyclonal antibody solution form amide bond; repeatedly wash the hydrogel with PBS buffer to remove unreacted EDC, NHS and β-glucuronidase polyclonal antibody solution; Preparation of core solution: 1% w / v The sodium hyaluronate solution was stirred until homogeneous under sterile conditions. The mixture was then added to a liquid culture medium containing activated flavonoids at a concentration of 10⁻⁶. 6 -10 9 Mix (CFU / mL) at a volume ratio of 1:1 and stir under aseptic conditions for 30 min.

[0034] (2) Preparation of microspheres: Connect each phase solution to the inlet of the microfluidic chip, turn on the injection pump, and adjust the flow rate of the inner phase to 5-10 μL / min; the flow rate of the intermediate phase to 30-40 μL / min; and the flow rate of the outer phase to 180-200 μL / min. After shearing out the microspheres, solidify them in the receiving phase for 30 min. Then, centrifuge the mixture in the collecting device at 1000 rpm for 5 min and collect the lower layer of hydrogel microspheres. Wash three times with sterile physiological saline to remove residual oil phase and uncrosslinked substances, and obtain core-shell hydrogel microspheres encapsulating flavogenic bacteria for later use.

[0035] (3) Microsphere inoculum load detection: 1.0 g of prepared microspheres were crushed and counted using the dilution plating method. The count result was 1.2*10⁻⁶. 12 CFU / mL.

[0036] (4) Preparation of injection solution: The gel microsphere solution of flavogenic bacteria is prepared by mixing the gel microspheres of flavogenic bacteria with physiological saline to form a dispersion solution.

[0037] (5) Cattle screening before puncture: Select 5 Simmental cattle or local yellow cattle (sex not limited) aged 6-8 months, weighing 300-500 kg, and in good health; exclude cattle with hepatobiliary diseases, infectious diseases and immunodeficiency through clinical examination (body temperature, heart rate, respiration) and laboratory tests (complete blood count, liver function, bile routine); number them WLKSYN0010, WLKSYN0011 and WLKSYN0012 respectively; Cattle restraint: Use the lateral recumbent restraint method to fix the cattle on a special restraint frame with the right side of the body facing up; shave the right rib area (10th-12th intercostal area) of the cattle, with a shaving area of ​​20 cm × 20 cm, and disinfect the area 3 times with iodine solution (disinfect in a spiral motion from the inside out, and the disinfection area extends 5 cm beyond the shaving area). cm); Anesthesia: Local infiltration anesthesia was used. 2% lidocaine solution was injected in a fan shape along the puncture point (the center of the gallbladder projection located by ultrasound). The anesthesia area was 5 cm in diameter and the depth reached the muscle layer. After anesthesia, wait 5 minutes to confirm the anesthetic effect.

[0038] (6) Puncture implantation: 20 mL of antibody-binding microspheres and 10 mL of Enterococcus faecalis were implanted into the Simmental cattle through puncture surgery. Ultrasound was used to ensure that the microspheres were implanted into the gallbladder.

[0039] (7) Feeding and extracting bezoar: The experimental cattle were fed normally. After 12 months of feeding, they were slaughtered and bezoar was extracted, yielding 32g of bezoar.

[0040] (8) The bilirubin content of the obtained bezoar was detected using the detection method under the entry for bezoar in Part I of the Chinese Pharmacopoeia 2025. The detection results are shown in Table 1. Table 1 Detection Results As shown in Table 1, when bacteria are introduced solely through puncture surgery for bezoar production, the colonization of the strains is unstable, the survival rate of the strains is low, and the production of bezoar and bilirubin cannot be stabilized. However, when microspheres containing flavonoid strains are used for post-injection bezoar production, the colonization and reproduction of the strains in the cattle are good, and a certain amount of bilirubin is produced. In contrast, when hydrogel core-shell microspheres are used for post-injection bezoar production, since they do not carry the relevant flavonoids, no related microorganisms colonize, and no bezoar or bilirubin is produced. Using core-shell microspheres with specific β-glucuronidase binding for post-injection bezoar production can effectively improve the colonization of relevant microorganisms, resulting in a significantly higher bezoar yield and higher bilirubin content compared to other comparative methods. This indicates that the method of this application improves both the yield and quality of bezoar.

[0041] The above description is merely a preferred embodiment of the present invention. It should be understood that the present invention is not limited to the forms disclosed herein and should not be construed as excluding other embodiments. It can be used in various other combinations, modifications, and environments, and can be altered within the scope of the concept described herein through the above teachings or related technologies or knowledge. Modifications and variations made by those skilled in the art that do not depart from the spirit and scope of the present invention should be within the protection scope of the appended claims.

Claims

1. A method for preparing core-shell hydrogel microspheres encapsulating flavonoids, characterized in that, Includes the following steps: S1: Preparation of external phase solution: Add surfactant ABIL EM90 to liquid paraffin, stir to dissolve it, add glacial acetic acid, shake to mix, and obtain the external phase solution; S2: Preparation of shell solution: Dissolve amino-containing biocompatible materials and carboxyl-containing biocompatible materials in MES buffer, and mix with Ca-EDTA solution to obtain shell base solution; add EDC and NHS to the shell base solution, then add β-glucuronidase polyclonal antibody solution, and shake the reaction at room temperature to form amide bonds between the amino groups and the carboxyl groups of the β-glucuronidase polyclonal antibody activated by EDC / NHS. After the reaction is completed, wash to obtain the shell solution; S3: Preparation of core solution: Mix liquid culture medium containing activated flavogenic bacteria and sodium hyaluronate solution at a volume ratio of 1:1 and stir to obtain the core solution; S4: Microfluidic preparation of core-shell droplet and microsphere formation: Using a microfluidic chip, a three-phase solution is injected into the microfluidic chip, so that the core solution is wrapped by the shell solution to form a core-shell bilayer droplet. Under the shearing action of the outer phase solution, it is dispersed into micron-sized droplets. The reaction continues, and the core-shell structure is completely solidified to obtain the suspension of the core-shell hydrogel microspheres encapsulating the flavonoid bacteria. S5: Microsphere collection: Centrifuge the suspension of the core-shell hydrogel microspheres encapsulating the flavogenic bacteria, collect the lower layer of the hydrogel microspheres, and wash them to obtain the core-shell hydrogel microspheres encapsulating the flavogenic bacteria.

2. The preparation method according to claim 1, characterized in that: The core-shell hydrogel microspheres encapsulating the flavogenic bacteria have a particle size of 50~500 μm and an encapsulation rate of ≥90% for the flavogenic bacteria.

3. The preparation method according to claim 1, characterized in that: In S1, the volume ratio of the liquid paraffin, the ABILEM90 and the glacial acetic acid is 100:3:1, the stirring speed is 150-500 rpm, and the stirring time is 6-10 h.

4. The preparation method according to claim 1, characterized in that: In S2, the pH of the MES buffer is 5.5, and the concentration of the Ca-EDTA solution is 240 mM; the molar ratio of carboxyl groups in the EDC, NHS, and β-glucuronidase polyclonal antibody is 0.6-1.2:0.5-1.0:0.8-1.4; the shaking reaction time is 4-6 h; the rinsing includes repeated rinsing with PBS buffer to remove unreacted EDC, NHS, and β-glucuronidase polyclonal antibody solution.

5. The preparation method according to claim 1, characterized in that: The carboxyl-containing biocompatible materials include hyaluronic acid, alginate, carboxymethyl cellulose, and PLGA; the amino-containing biocompatible materials include chitosan, gelatin, and aminoated PEG.

6. The preparation method according to claim 1, characterized in that: In S3, the concentration of the sodium hyaluronate solution is 1% w / v; the flavonoid bacteria are deposited at the Guangdong Provincial Microbial Culture Collection Center, with accession number GDMCC No. 65630, and the deposit date is December 13, 2024; the viable count of the flavonoid bacteria is 10. 6 ~10 9 CFU / mL; the stirring conditions were a sterile environment and the stirring time was 30 min.

7. The preparation method according to claim 1, characterized in that, In S4, the use of chip control includes: using a coaxial glass tube chip or PDMS chip as a microfluidic device, and using an injection pump to deliver the core solution at a flow rate of 2-20 µL / min; the shell solution at a flow rate of 5-50 µL / min; and the external phase solution at a flow rate of 40-200 µL / min; the duration of the continuous reaction is 30-480 min.

8. The preparation method according to claim 1, characterized in that: In S5, the centrifugation speed is 1000 rpm and the centrifugation time is 5 min; the washing includes washing 3 times with sterile physiological saline.

9. A flavogenic bacteria gel microsphere dispersion for injection, characterized in that: The dispersion is formed by uniformly dispersing the core-shell hydrogel microspheres encapsulating flavogenic bacteria as described in claims 1-8 in sterile physiological saline.

10. The method for preparing core-shell hydrogel microspheres encapsulating flavogenic bacteria as described in any one of claims 1-8, or the application of the flavogenic bacteria gel microsphere dispersion for injection as described in claim 9, in the in vivo culture of bezoar, characterized in that... The core-shell hydrogel microspheres encapsulating flavonoids are inoculated into the gallbladder or hepatobiliary-related sites of cattle or other ruminants, thereby promoting the efficient and stable production of bezoar in vivo under the growth and metabolism of flavonoids; wherein, the inoculation method includes puncture injection.

Citation Information

Patent Citations

  • Preparation process of in-vitro cultured calculus bovis

    CN117562927A

  • Composite xanthogenic bacterium and application thereof

    CN119351284A

  • Calculus bovis with combination of in-vitro cultivation and in-vivo cultivation and preparation method of calculus bovis

    CN119367398A